4 ms·
To be a little more precise: 1. "Prophylactic or therapeutic administration of neomycin provided significant protection against upper respiratory infection an
by youainti 2y ago
To be a little more precise:
1. "Prophylactic or therapeutic administration of neomycin provided significant protection against upper respiratory infection and lethal disease in a mouse model of COVID-19."
2. "Furthermore, neomycin treatment protected Mx1 congenic mice from upper and lower respiratory infections with a highly virulent strain of influenza A virus. "
3. "In Syrian hamsters, neomycin treatment potently mitigated contact transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)."
4. "In healthy humans, intranasal application of neomycin-containing Neosporin ointment was well tolerated and effective at inducing ISG expression in the nose in a subset of participants."
The mechanism appears to be that Neosporin triggers an ISG[1] (immune) response? Not a biologist etc, but the results showing that it prevents transmission is only in rodent models, and then showing that a similar biomarker shows up in (some of) the participants and the rodent models. They authors say:
> "These findings suggest that neomycin has the potential to be harnessed as a host-directed antiviral strategy for the prevention and treatment of respiratory viral infections."
[1]
- worstspotgain 2y agoStill early in the research, to be sure. Here's the human clinical study: https://classic.clinicaltrials.gov/ct2/show/NCT05449392 https://classic.clinicaltrials.gov/ct2/show/NCT05449392 Here's Eric Topol's chat with Iwasaki discussing the finding. Topol's blog may well be the best source for Covid research out there: https://erictopol.substack.com/p/akiko-iwasaki-the-immunology-of-covid https://erictopol.substack.com/p/akiko-iwasaki-the-immunolog...